Amandine Ruffier

Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial

Yungan Tao, J. Biau, X.S. Sun et al. · Annals of Oncology · 2022 · 166 citations · Full text

Ii Trial, Radiation Medicine, Radiation Therapy +10

Weekly Adaptive Radiotherapy vs Standard Intensity-Modulated Radiotherapy for Improving Salivary Function in Patients With Head and Neck Cancer

J. Castelli, Juliette Thariat, Karen Bénézery et al. · JAMA Oncology · 2023 · 58 citations · Full text

Inter-observer variability in target delineation increases during adaptive treatment of head-and-neck and lung cancer

Rudi Apolle, Steffen Appold, Henk P. Bijl et al. · Acta Oncologica · 2019 · 32 citations · Full text

Long-term outcomes and safety after reirradiation in locally recurrent nasopharyngeal carcinoma in a non-endemic area

Jihane Boustani, Amandine Ruffier, Antoine Moya‐Plana et al. · Strahlentherapie und Onkologie · 2020 · 15 citations

Esophageal Cancer, Non-endemic Area, Medicine +9

Prognostic factors in patients with soft palate squamous cell carcinoma

Antoine Schernberg, Charles Canova, Pierre Blanchard et al. · Head & Neck · 2019 · 13 citations